Protein Antigens Increase the Protective Efficacy of a Capsule-Based Vaccine against Staphylococcus aureus in a Rat Model of Osteomyelitis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protein Antigens Increase the Protective Efficacy of a Capsule-Based Vaccine against Staphylococcus aureus in a Rat Model of Osteomyelitis
Authors
Keywords
-
Journal
INFECTION AND IMMUNITY
Volume 82, Issue 1, Pages 83-91
Publisher
American Society for Microbiology
Online
2013-10-15
DOI
10.1128/iai.01050-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery
- (2013) Vance G. Fowler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genomic responses in mouse models poorly mimic human inflammatory diseases
- (2013) Junhee Seok et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Recombinant Clumping Factor A-Containing Vaccine Induces Functional Antibodies to Staphylococcus aureus That Are Not Observed after Natural Exposure
- (2012) Julio Hawkins et al. Clinical and Vaccine Immunology
- Challenges for a Universal Staphylococcus aureus Vaccine
- (2012) R. A. Proctor CLINICAL INFECTIOUS DISEASES
- Host Response Signature to Staphylococcus aureus Alpha-Hemolysin Implicates Pulmonary Th17 Response
- (2012) Karen M. Frank et al. INFECTION AND IMMUNITY
- Abscess Formation and Alpha-Hemolysin Induced Toxicity in a Mouse Model of Staphylococcus aureus Peritoneal Infection
- (2012) Sabine Rauch et al. INFECTION AND IMMUNITY
- Development of a multicomponentStaphylococcus aureusvaccine designed to counter multiple bacterial virulence factors
- (2012) Annaliesa S. Anderson et al. Human Vaccines & Immunotherapeutics
- High Prevalence of Isolates with Reduced Glycopeptide Susceptibility in Persistent or Recurrent Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus
- (2011) Ilker Uçkay et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Progress Toward a Staphylococcus aureus Vaccine
- (2011) R. S. Daum et al. CLINICAL INFECTIOUS DISEASES
- Will we ever see the approval of aStaphylococcus aureusvaccine?
- (2011) Joseph M Patti Expert Review of Anti-Infective Therapy
- Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responses
- (2011) Hwan Keun Kim et al. FASEB JOURNAL
- Scenery ofStaphylococcusimplant infections in orthopedics
- (2011) Lucio Montanaro et al. Future Microbiology
- Challenges for the evaluation ofStaphylococcus aureusprotein based vaccines: Monitoring antigenic diversity
- (2011) Ellen Murphy et al. Human vaccines & immunotherapeutics
- Immunotherapeutic approaches againstStaphylococcus aureus
- (2011) Nelianne J Verkaik et al. Immunotherapy
- Resolution ofStaphylococcus aureusBiofilm Infection Using Vaccination and Antibiotic Treatment
- (2011) Rebecca A. Brady et al. INFECTION AND IMMUNITY
- Staphylococcal Alpha-Toxin Is a Strong Inducer of Interleukin-17 in Humans
- (2011) Margarete Niebuhr et al. INFECTION AND IMMUNITY
- Novel targeted immunotherapy approaches for staphylococcal infection
- (2010) Michael Otto EXPERT OPINION ON BIOLOGICAL THERAPY
- Staphylococcus aureusadaptation to the host and persistence: role of loss of capsular polysaccharide expression
- (2010) Lorena Tuchscherr et al. Future Microbiology
- Role of Interleukin-17A in Cell-Mediated Protection against Staphylococcus aureus Infection in Mice Immunized with the Fibrinogen-Binding Domain of Clumping Factor A
- (2010) K. Narita et al. INFECTION AND IMMUNITY
- Identification of the active component that induces vancomycin resistance in MRSA
- (2010) Shinsuke Ikeda et al. JOURNAL OF ANTIBIOTICS
- Staphylococcus aureusSmall‐Colony Variants Are Adapted Phenotypes for Intracellular Persistence
- (2010) Lorena Tuchscherr et al. JOURNAL OF INFECTIOUS DISEASES
- Targeting of Alpha‐Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model
- (2010) Adam D. Kennedy et al. JOURNAL OF INFECTIOUS DISEASES
- A guide to defining and implementing protocols for the welfare assessment of laboratory animals: eleventh report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement
- (2010) P Hawkins et al. LABORATORY ANIMALS
- Community-associated meticillin-resistant Staphylococcus aureus
- (2010) Frank R DeLeo et al. LANCET
- NOD2 contributes to cutaneous defense against Staphylococcus aureus through -toxin-dependent innate immune activation
- (2009) P. Hruz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Incidence and Characteristics of Vancomycin Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus at Hershey Medical Center
- (2008) K. Kosowska-Shick et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibodies to Capsular Polysaccharide and Clumping Factor A Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants of Staphylococcus aureus in Mice
- (2008) L. P. N. Tuchscherr et al. INFECTION AND IMMUNITY
- Vaccination and passive immunisation against Staphylococcus aureus
- (2008) Adam C. Schaffer et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Vaccine protection againstStaphylococcus aureuspneumonia
- (2008) Juliane Bubeck Wardenburg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Fibrinogen Binding Sites P336 and Y338 of Clumping Factor A Are Crucial for Staphylococcus aureus Virulence
- (2008) Elisabet Josefsson et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started